BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1847224)

  • 1. VIP receptors from porcine liver: high yield solubilization in a GTP-insensitive form.
    Voisin T; Couvineau A; Guijarro L; Laburthe M
    Life Sci; 1991; 48(2):135-41. PubMed ID: 1847224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
    Guijarro L; Couvineau A; Calvo JR; Laburthe M
    Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M; Carlquist M; Maletti M; Marie JC
    FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S; Said SI
    J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S; Veliçelebi G
    Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G
    Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
    Couvineau A; Amiranoff B; Laburthe M
    J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine.
    Calvo JR; Couvineau A; Guijarro L; Laburthe M
    Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography.
    Couvineau A; Voisin T; Guijarro L; Laburthe M
    J Biol Chem; 1990 Aug; 265(22):13386-90. PubMed ID: 2165502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
    Couvineau A; Gammeltoft S; Laburthe M
    J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.
    Nguyen TD; Kaiser LM
    Peptides; 1990; 11(6):1255-61. PubMed ID: 1965036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.
    Couvineau A; Rouyer-Fessard C; Voisin T; Laburthe M
    Eur J Biochem; 1990 Feb; 187(3):605-9. PubMed ID: 2154377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
    Patthi S; Simerson S; Veliçelebi G
    J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
    Guijarro LG; Rodriguez-Pena MS; Prieto JC
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
    Pineau N; Lelievre V; Goursaud S; Hilairet S; Waschek JA; Janet T; Muller JM
    Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.